MedPath

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder

Not Applicable
Completed
Conditions
Autism Spectrum Disorders
Registration Number
NCT01691066
Lead Sponsor
Yale University
Brief Summary

The purpose of this study aims to investigate the utility of Pivotal Response Treatment (PRT), a behaviorally derived intervention, to improve the quality and frequency of communication and social engagement of toddlers with siblings who have an autism spectrum disorder (SIBS - ASD) and who demonstrate developmental delays and impairments in social interaction between 12 and 15 months of age.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • toddlers, age 12 - 15 months, who have an older sibling with ASD
  • delays of at least 1.5 standard deviations in communication (receptive/expressive language) based on developmental testing
  • scores that exceed the ASD cutoff on standardized measures of social-communicative behavior
Exclusion Criteria
  • physical or neurological disorder (e.g., seizures, cerebral palsy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Feasibility of a novel behavioral treatment24 months

Assessment of Outcome:

Attendance. Attendance to parent education sessions will be recorded by the therapist.

Parent utilization. To assess the acceptability of the PRT approach, parents will be asked to keep a weekly log of procedure use, including overall estimated duration and choice of activities.

Acceptability of a novel behavioral treatment24 months

Assessment of Outcome:

Parent satisfaction. At post-treatment, parents will be asked to complete a Likert-scale and short response questionnaire rating their satisfaction with various aspects of the program

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yale Child Study Center

🇺🇸

New Haven, Connecticut, United States

Yale Child Study Center
🇺🇸New Haven, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.